These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 10485504

  • 1. Lansoprazole versus omeprazole for duodenal ulcer healing and prevention of relapse: a randomized, multicenter, double-masked trial.
    Dobrilla G, Piazzi L, Fiocca R.
    Clin Ther; 1999 Aug; 21(8):1321-32. PubMed ID: 10485504
    [Abstract] [Full Text] [Related]

  • 2. [Comparison of lansoprazole (30 mg) and omeprazole (20 mg) in the treatment of duodenal ulcer. A multicenter double-blind comparative trial].
    Petite JP, Slama JL, Licht H, Lemerez M, Coste T, Andrieu J, Grimaud JC, Julien H, Dupuis J, Sallerin V.
    Gastroenterol Clin Biol; 1993 Aug; 17(5):334-40. PubMed ID: 8349067
    [Abstract] [Full Text] [Related]

  • 3. A comparison of three doses of lansoprazole (15, 30 and 60 mg) and placebo in the treatment of duodenal ulcer. The Lansoprazole Study Group.
    Avner DL, Dorsch ER, Jennings DE, Greski-Rose PA.
    Aliment Pharmacol Ther; 1995 Oct; 9(5):521-8. PubMed ID: 8580272
    [Abstract] [Full Text] [Related]

  • 4. Bedtime administration of lansoprazole does not modify its greater efficacy vs ranitidine in the acute and long-term treatment of duodenal ulcer. Results from a multicentre, randomised, double blind clinical trial.
    Russo A, Dattilo M.
    Ital J Gastroenterol Hepatol; 1997 Aug; 29(4):312-9. PubMed ID: 9476183
    [Abstract] [Full Text] [Related]

  • 5. Continuous maintenance with low-dose lansoprazole versus Helicobacter pylori eradication in the prevention of duodenal ulcer recurrence.
    Parente F, Bargiggia S, Bollani S, Colombo E, Bianchi Porro G.
    Hepatogastroenterology; 1998 Aug; 45(22):990-3. PubMed ID: 9755995
    [Abstract] [Full Text] [Related]

  • 6. Lansoprazole is superior to ranitidine as maintenance treatment for the prevention of duodenal ulcer relapse.
    Bardhan KD, Crowe J, Thompson RP, Trewby PN, Keeling PN, Weir D, Crouch SL.
    Aliment Pharmacol Ther; 1999 Jun; 13(6):827-32. PubMed ID: 10383514
    [Abstract] [Full Text] [Related]

  • 7. Comparison of lansoprazole-based triple and dual therapy for treatment of Helicobacter pylori-related duodenal ulcer: an Asian multicentre double-blind randomized placebo controlled study.
    Wong BC, Xiao SD, Hu FL, Qian SC, Huang NX, Li YY, Hu PJ, Daldiyono, Manan C, Lesmana L, Carpio RE, Perez JY, Fock KM, Kachintorn U, Phornphutkul K, Kullavanijaya P, Ho J, Lam SK.
    Aliment Pharmacol Ther; 2000 Feb; 14(2):217-24. PubMed ID: 10651663
    [Abstract] [Full Text] [Related]

  • 8. Dose-related healing of duodenal ulcer with the proton pump inhibitor lansoprazole.
    Londong W, Barth H, Dammann HG, Hengels KJ, Kleinert R, Müller P, Rohde H, Simon B.
    Aliment Pharmacol Ther; 1991 Jun; 5(3):245-54. PubMed ID: 1888824
    [Abstract] [Full Text] [Related]

  • 9. Comparison of lansoprazole and omeprazole in the short-term management of duodenal ulcers in Taiwan.
    Chang FY, Chiang CY, Tam TN, Ng WW, Lee SD.
    J Gastroenterol Hepatol; 1995 Jun; 10(5):595-601. PubMed ID: 8963037
    [Abstract] [Full Text] [Related]

  • 10. Lansoprazole-based triple therapy versus ranitidine bismuth citrate-based dual therapy in the eradication of Helicobacter pylori in patients with duodenal ulcer: a multicenter, randomized, double-dummy study.
    Luzza F, Giglio A, Ciliberto E, Belmonte A, Cavaliere C, Saccà N, Frandina C, Fiocca R, Trimboli V, Pallone F.
    Clin Ther; 2001 May; 23(5):761-70. PubMed ID: 11394734
    [Abstract] [Full Text] [Related]

  • 11. Improved symptom relief and duodenal ulcer healing with lansoprazole, a new proton pump inhibitor, compared with ranitidine.
    Hawkey CJ, Long RG, Bardhan KD, Wormsley KG, Cochran KM, Christian J, Moules IK.
    Gut; 1993 Oct; 34(10):1458-62. PubMed ID: 8244121
    [Abstract] [Full Text] [Related]

  • 12. Triple versus dual therapy for eradicating Helicobacter pylori and preventing ulcer recurrence: a randomized, double-blind, multicenter study of lansoprazole, clarithromycin, and/or amoxicillin in different dosing regimens.
    Schwartz H, Krause R, Sahba B, Haber M, Weissfeld A, Rose P, Siepman N, Freston J.
    Am J Gastroenterol; 1998 Apr; 93(4):584-90. PubMed ID: 9576452
    [Abstract] [Full Text] [Related]

  • 13. Lansoprazole versus famotidine: efficacy and tolerance in the acute management of duodenal ulceration.
    Hotz J, Kleinert R, Grymbowski T, Hennig U, Schwarz JA.
    Aliment Pharmacol Ther; 1992 Feb; 6(1):87-95. PubMed ID: 1543819
    [Abstract] [Full Text] [Related]

  • 14. Progress with proton pump inhibitors in acid peptic disease: treatment of duodenal and gastric ulcer.
    Florent C.
    Clin Ther; 1993 Feb; 15 Suppl B():14-21. PubMed ID: 7911399
    [Abstract] [Full Text] [Related]

  • 15. Double-blind comparison of lansoprazole, ranitidine, and placebo in the treatment of acute duodenal ulcer. Lansoprazole Study Group.
    Lanza F, Goff J, Scowcroft C, Jennings D, Greski-Rose P.
    Am J Gastroenterol; 1994 Aug; 89(8):1191-200. PubMed ID: 8053433
    [Abstract] [Full Text] [Related]

  • 16. Lansoprazole versus omeprazole in active duodenal ulcer. A double-blind, randomized, comparative study.
    Ekström P, Carling L, Unge P, Anker-Hansen O, Sjöstedt S, Sellström H.
    Scand J Gastroenterol; 1995 Mar; 30(3):210-5. PubMed ID: 7770708
    [Abstract] [Full Text] [Related]

  • 17. Effect of lansoprazole on peptic ulcers.
    Ohashi T, Sakata J, Haraguchi Y, Eto T.
    J Clin Gastroenterol; 1995 Mar; 20 Suppl 2():S83-5. PubMed ID: 7594350
    [Abstract] [Full Text] [Related]

  • 18. Healing and relapse rates in gastroesophageal reflux disease treated with the newer proton-pump inhibitors lansoprazole, rabeprazole, and pantoprazole compared with omeprazole, ranitidine, and placebo: evidence from randomized clinical trials.
    Caro JJ, Salas M, Ward A.
    Clin Ther; 2001 Jul; 23(7):998-1017. PubMed ID: 11519776
    [Abstract] [Full Text] [Related]

  • 19. Superiority of lansoprazole vs ranitidine in healing nonsteroidal anti-inflammatory drug-associated gastric ulcers: results of a double-blind, randomized, multicenter study. NSAID-Associated Gastric Ulcer Study Group.
    Agrawal NM, Campbell DR, Safdi MA, Lukasik NL, Huang B, Haber MM.
    Arch Intern Med; 2000 May 22; 160(10):1455-61. PubMed ID: 10826458
    [Abstract] [Full Text] [Related]

  • 20. Triple therapy for Helicobacter pylori eradication is more effective than long-term maintenance antisecretory treatment in the prevention of recurrence of duodenal ulcer: a prospective long-term follow-up study.
    Wong BC, Lam SK, Lai KC, Hu WH, Ching CK, Ho J, Yuen ST, Chan CK, Lau GK, Lai CL.
    Aliment Pharmacol Ther; 1999 Mar 22; 13(3):303-9. PubMed ID: 10102962
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.